The DNA methylation landscape of advanced prostate cancer.

Although DNA methylation is a key regulator of gene expression, the comprehensive methylation landscape of metastatic cancer has never been defined. Through whole-genome bisulfite sequencing paired with deep whole-genome and transcriptome sequencing of 100 castration-resistant prostate metastases, we discovered alterations affecting driver genes that were detectable only with integrated whole-genome approaches. Notably, we observed that 22% of tumors exhibited a novel epigenomic subtype associated with hypermethylation and somatic mutations in TET2, DNMT3B, IDH1 and BRAF. We also identified intergenic regions where methylation is associated with RNA expression of the oncogenic driver genes AR, MYC and ERG. Finally, we showed that differential methylation during progression preferentially occurs at somatic mutational hotspots and putative regulatory regions. This study is a large integrated study of whole-genome, whole-methylome and whole-transcriptome sequencing in metastatic cancer that provides a comprehensive overview of the important regulatory role of methylation in metastatic castration-resistant prostate cancer.

Nature genetics. 2020 Jul 13 [Epub ahead of print]

Shuang G Zhao, William S Chen, Haolong Li, Adam Foye, Meng Zhang, Martin Sjöström, Rahul Aggarwal, Denise Playdle, Arnold Liao, Joshi J Alumkal, Rajdeep Das, Jonathan Chou, Junjie T Hua, Travis J Barnard, Adina M Bailey, Eric D Chow, Marc D Perry, Ha X Dang, Rendong Yang, Ruhollah Moussavi-Baygi, Li Zhang, Mohammed Alshalalfa, S Laura Chang, Kathleen E Houlahan, Yu-Jia Shiah, Tomasz M Beer, George Thomas, Kim N Chi, Martin Gleave, Amina Zoubeidi, Robert E Reiter, Matthew B Rettig, Owen Witte, M Yvonne Kim, Lawrence Fong, Daniel E Spratt, Todd M Morgan, Rohit Bose, Franklin W Huang, Hui Li, Lisa Chesner, Tanushree Shenoy, Hani Goodarzi, Irfan A Asangani, Shahneen Sandhu, Joshua M Lang, Nupam P Mahajan, Primo N Lara, Christopher P Evans, Phillip Febbo, Serafim Batzoglou, Karen E Knudsen, Housheng H He, Jiaoti Huang, Wilbert Zwart, Joseph F Costello, Jianhua Luo, Scott A Tomlins, Alexander W Wyatt, Scott M Dehm, Alan Ashworth, Luke A Gilbert, Paul C Boutros, Kyle Farh, Arul M Chinnaiyan, Christopher A Maher, Eric J Small, David A Quigley, Felix Y Feng

Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA., Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA., Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Illumina Inc., San Diego, CA, USA., Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA., McDonnell Genome Institute, Washington University, St. Louis, MO, USA., The Hormel Institute, University of Minnesota, Austin, MN, USA., Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Jonsson Comprehensive Cancer Center, Departments of Medicine and Urology, University of California Los Angeles, Los Angeles, CA, USA., Department of Microbiology, Immunology, and Molecular Genetics at the David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA., Department of Cancer Biology, University of Pennsylvania, Philadelphia, PA, USA., Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia., Department of Medicine, University of Wisconsin, Madison, WI, USA., Siteman Cancer Center, Washington University, St. Louis, MO, USA., Division of Hematology Oncology, Department of Internal Medicine, University of California Davis, Sacramento, CA, USA., Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA., Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA., Department of Pathology, Duke University, Durham, NC, USA., Netherlands Cancer Institute, Oncode Institute, Amsterdam, the Netherlands., Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA., Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA., Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA., Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada., Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA. .